ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2069

Responsiveness of the Patient Reported Outcomes Measurement Information System (PROMIS) Computerized Adaptive Test (CAT) Measures in a Single Canadian Lupus Cohort

Aarabi Thayaparan1, Patricia Katz2, Mitra Moazzami3, Dennisse Bonilla1, Lisa Engel4, Jiandong Su1, Pooneh Akhavan5, Sherief Marzouk6, Nathalie Rozenbojm7, Nicole Anderson1, Oshrat Tayer-Shifman8, Dorcas Beaton9 and Zahi Touma1, 1Schroeder Arthritis Institute, Krembil Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada, 2UCSF, San Rafael, CA, 3George Washington University, Washington, DC, 4University of Manitoba, Winnipeg, MB, Canada, 5Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 6University Health Network, University of Toronto, Toronto, ON, Canada, 7University Health Network, Toronto, ON, Canada, 8Meir Medical Center, Kfar Saba, Israel, 9Institute for Work & Health, Toronto, ON, Canada

Meeting: ACR Convergence 2022

Keywords: longitudinal studies, Patient reported outcomes, Psychometrics

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2022

Title: SLE – Diagnosis, Manifestations, and Outcomes Poster III: Outcomes

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Clinicians should include Patient-Reported Outcome (PRO) measures in the assessment of lupus patients, as they are crucial in providing patient-centred care. The Patient Reported Outcomes Measurement Information System (PROMIS) is a relatively new set of person-centered measures that describes and evaluates physical, mental, and social health. Our previous studies have demonstrated reliability and validity evidence for the PROMIS computerized adaptive test (CAT) in patients with systemic lupus erythematosus (SLE). This study extends this evidence by examining the responsiveness of the PROMIS CAT. We hypothesized that PROMIS CAT domains will show a change when the patient reports worsening or improvement.

Methods: In this longitudinal single centre study, consecutive adult English-speaking SLE patients completed an assessment using PROMIS CAT’s 13 domains (physical function, mobility, pain behaviour, pain interference, ability to participate in social roles, satisfaction with social roles and activities, fatigue, sleep disturbance, sleep-related impairment, applied cognition-general concerns, anger, anxiety, and depression) at baseline and 6 month follow-up. We asked the generic anchor question “Compared to when you started the study, how have you been during the last 48 hours?” (same, worse, no change) at 6 months to identify those with symptom severity change. Domain-specific anchor questions aligning with the PROMIS CAT domains were also asked at 6 months with responses graded from -7 (greatest worsening) to +7 (greatest improvement); 0 represented no change. For domain-specific anchors, improvement was defined as >1, and worsening as < -1. We assessed responsiveness by examining effect size (ES) and standardized response means (SRM) in patients with improvement and worsening (ES, SRM categorized as low: 0.3-0.5; moderate: 0.5-0.8; high: >0.8). We also assessed the Spearman correlation between the change of external anchors (general and domain specific) and the change of PROMIS CAT domains between baseline and 6 months (defined as weak: < 0.3; moderate: 0.3-0.7; strong: >0.7).

Results: 108 patients were included. Baseline characteristics are in Table 1. Table 2 demonstrates correlation coefficients, SRM and ES at 6 months for both the general anchor and domain-specific questions. Correlation of change in anchor measures with change in PROMIS CAT was weak-moderate in patients with better and worse categories. SRM and ES showed small-moderate effect for patients that reported better and worse health and consistently small to no effect in patients reporting no change, indicating PROMIS CAT is measuring the domains adequately as captured by the general anchor. More moderate SRM and effect sizes were noted in the domain specific anchors compared to general. 9 out of 13 domains had moderate SRMs and ES, particularly with domain-specific anchors.

Conclusion: PROMIS CAT detected improvement and worsening over time in most domains in patients with SLE in concordance with the external anchors, supporting its responsiveness in this population for most but not all types of change.

Supporting image 1

Table 1. Cohort Characteristics at Baseline (n=108)

Supporting image 2

Table 2. Results of Responsiveness at 6 Months
Spearman correlation: *moderate: 0.3-0.7; **strong: >0.7


Disclosures: A. Thayaparan, None; P. Katz, None; M. Moazzami, None; D. Bonilla, None; L. Engel, None; J. Su, None; P. Akhavan, None; S. Marzouk, None; N. Rozenbojm, None; N. Anderson, None; O. Tayer-Shifman, None; D. Beaton, None; Z. Touma, None.

To cite this abstract in AMA style:

Thayaparan A, Katz P, Moazzami M, Bonilla D, Engel L, Su J, Akhavan P, Marzouk S, Rozenbojm N, Anderson N, Tayer-Shifman O, Beaton D, Touma Z. Responsiveness of the Patient Reported Outcomes Measurement Information System (PROMIS) Computerized Adaptive Test (CAT) Measures in a Single Canadian Lupus Cohort [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/responsiveness-of-the-patient-reported-outcomes-measurement-information-system-promis-computerized-adaptive-test-cat-measures-in-a-single-canadian-lupus-cohort/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/responsiveness-of-the-patient-reported-outcomes-measurement-information-system-promis-computerized-adaptive-test-cat-measures-in-a-single-canadian-lupus-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology